Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2025-10-17 00:00:00 ET · period of report 2025-10-15 · accession 0001214659-25-015047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-17 | 2025-10-15 | AQST | Kraus Carl N | Chief Medical Off | S - Sale | $7.00 | -20.3K | 282.5K | -7% | -$141.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-15 | S | D | 20,272 | $7.00 | 282,475 | D | — | — | (F2) The reported transaction involves sale transactions from $7.00 to $7.02 per share. The weighted average price per share was $7.00. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |